Charterhouse Partners With Tunstall for Future Growth

TunstallTunstall Group, the market leading provider of telecare and telehealth solutions, has undertaken an extensive strategic review of its business, and has found an excellent new partner in Charterhouse Capital Partners, further strengthening the Group's future growth plans.

Charterhouse is a successful British business with a 30-year track record and is committed to backing the Tunstall management team to achieve its vision. They join Bridgepoint, Tunstall's previous majority shareholder, who become a minority shareholder in the business.

Tunstall's solutions support over 2.5 million people worldwide allowing them to live independently, by effectively managing their health and well-being. Telecare is increasingly recognised as being at the heart of modern health and social care systems and Tunstall's aim is to deliver a broader range of services to effectively assist more people by providing flexible, timely, and proactive support.

James Buckley, Chief Executive, Tunstall Group said, "I am delighted to be working with Charterhouse to realise our vision of improving the quality of life for many more people in the future. Telecare plays a key role in delivering personalised care to support people with health and social care needs, their families and carers. Our aim is to offer even more enhanced levels of support, drive forward our technology plans and work with our customers to provide effective solutions for a diverse range of people across the globe and I believe we have found the right team to help us achieve our ambitions."

Jeremy Greenhalgh, Partner, Charterhouse added "It is clear that Tunstall is a very successful business with attractive solutions in a market that is experiencing ageing demographics and the emergence of lifestyle epidemics such as obesity and chronic disease. Governments around the world are recognising the compelling economics of telecare and telehealth and I am looking forward to working with the team to deliver its plans for the future."

Related news articles:

About Tunstall
Tunstall is the market leading provider of telecare and telehealth solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives. For more information on how telecare and telehealth can improve quality of life, visit www.tunstall.co.uk.

About Charterhouse
Charterhouse Capital Partners leads and invests in large European buy-outs and has been doing so since the early days of the buy-out market in the 1980's. With over 128 transactions, worth an aggregate €38bn in transaction value, and with 89% of those investments realised, we believe that our track record and experience combine to make us one of the most successful private equity firms in Europe. www.charterhouse.co.uk

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...